China Transplantation Market Size & Outlook, 2023-2030
China transplantation market, 2018-2030 (US$M)
Related Markets
China transplantation market highlights
- The China transplantation market generated a revenue of USD 951.1 million in 2023 and is expected to reach USD 1,902.8 million by 2030.
- The China market is expected to grow at a CAGR of 10.4% from 2024 to 2030.
- In terms of segment, tissue products was the largest revenue generating product in 2023.
- Immunosuppressive Drugs is the most lucrative product segment registering the fastest growth during the forecast period.
Transplantation market data book summary
| Market revenue in 2023 | USD 951.1 million |
| Market revenue in 2030 | USD 1,902.8 million |
| Growth rate | 10.4% (CAGR from 2023 to 2030) |
| Largest segment | Tissue products |
| Fastest growing segment | Immunosuppressive Drugs |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Immunosuppressive Drugs, Tissue Products, Preservation Solutions |
| Key market players worldwide | AbbVie Inc, Arthrex, Zimmer Biomet Holdings Inc, Medtronic PLC, Novartis AG ADR, Stryker Corp, BioLife Solutions Inc, Teva Pharmaceutical Industries Ltd, Asahi Kasei Corp |
Other key industry trends
- In terms of revenue, China accounted for 5.7% of the global transplantation market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China transplantation market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,424.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Transplantation Market Scope
Transplantation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China transplantation market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to transplantation market will help companies and investors design strategic landscapes.
Tissue products was the largest segment with a revenue share of 57.55% in 2023. Horizon Databook has segmented the China transplantation market based on immunosuppressive drugs, tissue products, preservation solutions covering the revenue growth of each sub-segment from 2018 to 2030.
China accounted for a major share in the Asia Pacific in 2019, which can be attributed to favorable government reforms and rising prevalence of chronic diseases. In May 2017, the transplant hospitals were increased from 169 to 173 by the Chinese government. The government aims to increase the number of hospitals to 300 by 2020, to perform a greater number of transplant surgeries.
According to the China Organ Harvest Research Center, China performed 50% more transplant procedures in 2017, in comparison with 2016. In 2017, a nonprofit organization named China Organ Harvest Research Center (COHRC) was established to research organ transplant abuse in China, to safeguard human dignity and promote a positive growth factor.
Reasons to subscribe to China transplantation market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China transplantation market databook
-
Our clientele includes a mix of transplantation market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China transplantation market , including forecasts for subscribers. This country databook contains high-level insights into China transplantation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China transplantation market size, by product, 2018-2030 (US$M)
China Transplantation Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
